A Proof-of-Concept Study Evaluating the Phosphodiesterase 10A Inhibitor PF-02545920 in the Adjunctive Treatment of Suboptimally Controlled Symptoms of Schizophrenia.
- Resource Type
- Article
- Source
- Journal of Clinical Psychopharmacology; Jul/Aug2019, Vol. 39 Issue 4, p318-328, 11p
- Subject
- Language
- ISSN
- 02710749